General Information of the Compound
Compound ID
CP0095473
Compound Name
US10525036, Example GDC-0994
    Show/Hide
Synonyms
GDC-0994
    Show/Hide
Structure
Formula
C21H18ClFN6O2
Molecular Weight
440.866
Canonical SMILES
Cn1nccc1Nc1nccc(n1)-c1ccn([C@H](CO)c2ccc(Cl)c(F)c2)c(=O)c1
    Show/Hide
InChI
InChI=1S/C21H18ClFN6O2/c1-28-19(5-8-25-28)27-21-24-7-4-17(26-21)13-6-9-29(20(31)11-13)18(12-30)14-2-3-15(22)16(23)10-14/h2-11,18,30H,12H2,1H3,(H,24,26,27)/t18-/m1/s1
    Show/Hide
InChIKey
RZUOCXOYPYGSKL-GOSISDBHSA-N
CAS
1453848-26-4
Physicochemical Property
logP
3.1566
Rotatable Bonds
6
Heavy Atom Count
31
Polar Areas
97.86
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
8
Complexity
31

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 71727581
ChEMBL ID
CHEMBL3544964
DrugBank ID
DB15281
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00850, Mitogen-activated protein kinase 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000045 A-375 Homo sapiens (Human)  2
1
IC50 = 86 nM
   TI
   LI
   LO
   TS
2
IC50 = 140 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 0.3 nM
2 IC50 = 3.1 nM
3 IC50 = 3.3 nM
4 Kd = 1.585 nM
Protein ID: PT02162, Mitogen-activated protein kinase 6
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 21800 nM
   TI
   LI
   LO
   TS
CL000012 Sf21 Spodoptera frugiperda (Fall armyworm)  1
1
Kd = 25000 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( GDC-0994 )
Drug Name GDC-0994
Company Genentech
Indication
Solid tumour/cancer
Phase 1
Target(s)
Extracellular signal-regulated kinase 1 (ERK1)
Modulator
Extracellular signal-regulated kinase 2 (ERK2)
Modulator